Instrument Business Outlook Volume 33 - Issue 11

17 Sep 2024

Categories:

Instrument Business Outlook

Table of Contents

The IBO 2024 Design Awards
- Gold Award: Xevo MRT MS
- Silver Award: JEM-120i TEM
- Bronze Award: Regula 5006 Spectrometer-Microscope
Executive Briefing
- Antylia Up for Sale
- Oxford Nanopore Takes Legal Action Against MGI
- Singular Genomics Receives Non-Binding Acquisition Proposal
- Calibre Buys Chromatography Company and Service Company
- Bionano to Lay Off 84 Employees
Second Quarter Results: Biotage, Pacific Biosciences, QIAGEN, Shimadzu AMI and Tecan
- Biotage Post Solid Sales in the Americas and EMEA
- Pacific Biosciences’ System Sales Struggle
- QIAGEN Revises 2024 Forecast Due to Business Change
  - Product Lines
  - Regions
  - Guidance
- Shimadzu AMI Feels Impact of Weak Chinese Market
  - Product Lines
  - End-Markets
  - Geography
  - Guidance
- Tecan Struggles in China
  - Orders
  - Life Sciences
  - Partnering
  - Guidance
Market Profile: RNA Transfection Reagents
- Leading Vendors
- Largest Markets
- Reagent Cost
Industry Watch
- Biopharma: Challenges of Developing Oncology Therapeutics
- Government and Chemicals: PFAS Strategic Plan
- Semiconductors: CHIPS ACT and R&D Funding
Region Watch
- China: Survey Shows US Companies’ Views on China
- Canada: Biotech and Other R&D Spending
- India: New Biomanufacturing Policy
News
- Broad-Based Companies
  - Company Announcements
- Chromatography
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Life Science Instruments
  - Gene-Based Analysis
  - Company Announcements
  - Product Introductions
  - Cell-Based Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
  - Protein-Based Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Informatics
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
Bottom Line

Attachments

IBO 091624 Issue.pdf